CLINICAL_TRIALS
trial_result
· 2023-10-27
Clinical Trial Update: A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis [Phase 2]
Summary
Phase 2 clinical trial update for LNK01001 capsule in patients with ankylosing spondylitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lynk Pharmaceuticals Co., Ltd | Conditions: Ankylosing Spondylitis | Phase 2 | Status: COMPLETED